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ABSTRACT 
Cadmium (Cd) is carcinogenic and a well-established human health risk. 
Epidemiological and experimental studies have demonstrated that Cd is associated 
with breast cancer. We reported previously that Cd promoted breast cancer cell 
growth. Whether Cd treatment also causes epithelial-mesenchymal transition (EMT) 
and progression to metastasis in breast epithelial cells is unknown. The dissertation 
described here investigated the effect of Cd in breast cancer progression.  
Noncancerous breast epithelial MCF10A cells, non-metastatic HCC 1937 and 
HCC 38 cells, and metastatic MDA-MB-231 cells were treated with 1 or 3 µM Cd for 
4 weeks. The increase in the expressions of N-cadherin and vimentin but decrease in 
the expressions of E-cadherin and claudin-1 indicated that these epithelial cells were 
transformed to mesenchymal-like upon prolonged Cd treatment. Treatment of 
MCF10A-Zcad and MDA-MB-231-Zcad cells with 1 or 3 µM Cd showed the 
suppression of E-cadherin transcription and an increase in the translation of ZEB-1, 
suggesting that transcription factors were involved in the EMT process. The 
accumulation of Snail in the nucleus of cells treated with Cd for 4 weeks confirmed 
that Cd affected the expression of the EMT regulator. Inhibition of transcription by 
actinomycin D eliminated the Cd-induced Snail accumulation. However, inhibition of 
nuclear export by leptomycin B had an additive effect on Cd-induced Snail expression. 
Based on these results, it appears that Cd induces EMT in breast epithelial cells by 
modulating the transcription of Snail. 
The effects of Cd on metastasis-associated phenotypes were investigated in 
MDA-MB-231 cells. Treatment of the metastatic cells with 1 or 3 µM Cd for 1-6 h 
  
resulted in cell spreading. The activation of integrin β1, FAK, Src, and Rac1 indicated 
the involvement of integrin signaling in Cd-induced cell spreading. Treatment with 1 
or 3 μM Cd also inhibited GSK3β and induced T-cell factor/lymphoid enhancer factor 
(TCF/LEF) transcription, suggesting the involvement of Wnt/β-catenin pathway. 
Furthermore, treatment with 3 μM Cd for 4 weeks increased β-catenin expression, 
resulting in enhanced TCF/LEF transcription. Prolonged Cd treatment elevated the 
expression of integrin α5 and β1, paxillin, and vimentin. This indicated cytoskeleton 
remodeling leading to malignancy, as evidenced by enhanced matrix metalloprotease 
2/9 (MMP2/9) secretion and cell invasion. Furthermore, prolonged Cd treatment 
increased cell growth rate. Together, these results suggest that Cd alters integrin and 
β-catenin signaling involved in regulation of cytoskeleton and enhances cancer cell 
migration, adhesion, invasion, and proliferation.  
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PREFACE 
This dissertation was prepared according to the manuscript format.  
Two manuscripts will be submitted to Toxicology and Applied Pharmacology 
with the following tentative titles: 
I. Epithelial-mesenchymal transition in breast epithelial cells upon treatment with 
cadmium 
II. Cadmium enhances metastasis-associated phenotypes in breast cancer cells 
through integrin and β-catenin signaling 
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CHAPTER 1 
 
INTRODUCTION 
1. Toxicity of cadmium  
Cadmium (Cd) is a transition metal. Typical industrial uses for Cd are in batteries, 
alloys, electroplating, plastic stabilizers, and pigments. Cd and its compounds are 
highly toxic. Bioaccumulation of Cd in body interferes with normal physiological 
functions. The general population is exposed to Cd through dietary intake, smoking, 
and polluted air. Dietary Cd intake ranges from 0.5-55 μg/day (Cho et al., 2013). 
Absorbed Cd mainly binds to metallothionein or other cysteine-rich proteins in various 
organs, such as liver, kidney, lungs, prostate, spleen, mammary gland, and heart 
(Johnson et al., 2003; Waalkes, 2003). Therefore, acute or chronic exposure to Cd 
causes non-cancer disorder in cardiovascular, renal, bone, gastrointestinal, 
neurological, reproductive, immune, and respiratory systems. Moreover, occupational 
exposure to Cd through inhalation has been associated with lung cancer (Stayner et al., 
1992). It raises the question, should Cd be considered as a carcinogen in the general 
population. 
 
2. Epidemiological studies linking cadmium and cancer 
A number of epidemiological studies have evaluated the association between 
cancer risk and Cd exposure in the general population in recent years (Adams et al., 
2012b; Julin et al., 2012; Sawada et al., 2012; Nagata et al., 2013). Meta-analysis of 
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the data found that Cd exposure correlated to higher risks of breast, prostate, lung, 
kidney, and pancreas cancers (Cho et al., 2013).  
A case-control study in Japan reported that high dietary Cd intake increased the 
risk of breast cancer in postmenopausal women, specifically the ER+ subtype (Itoh et 
al., 2014). However, another retrospective cohort study conducted in the United States 
reported that dietary Cd was not associated with the risk of invasive breast cancer in 
postmenopausal women (Adams et al., 2012a). Moreover, a more recent meta-analysis 
of six studies linking dietary Cd and postmenopausal breast cancer reported no 
significant increase in breast cancer risk among postmenopausal women with higher 
dietary Cd intake (Van Maele-Fabry et al., 2016). One possible explanation for these 
contradictory conclusions could be the differences in Food Frequency Questionnaire 
(FFQ) that was used to estimate the dietary Cd intake level. Another prospective 
cohort study validated dietary Cd intake level through comparison with urinary Cd 
levels to avoid the bias or inaccuracy in FFQ design. In that study, the higher dietary 
Cd level was associated with higher breast cancer incidence, regardless of ER status. 
(Julin et al., 2012). Additionally, several studies of breast cancer incidence and 
cadmium exposure concluded that breast cancer risk was associated with higher Cd in 
urine or blood (McElroy et al., 2006; Wu et al., 2006; Gallagher et al., 2010; Rahim et 
al., 2013). Therefore, it seems that the method to assess Cd exposure affects the 
accuracy of the correlation study. EPA and IARC have categorized Cd as a probable 
human carcinogen since the controversial conclusions in epidemiological studies. It 
also motivated investigations into studying the carcinogenic effect of Cd in animal 
models and cell lines.  
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3. Carcinogenesis of cadmium in animals 
Studies in mice and rats indicated that Cd exposure caused the development of 
different types of cancers. Depending on the exposure route, tumors developed in 
different organs. Oral administration resulted in leukemia and testicular tumors in the 
Wistar rats (Waalkes and Rehm, 1992). Exposure to Cd aerosol caused lung 
adenocarcinomas in the Wistar rats (Takenaka et al., 1983). Subcutaneous injection of 
CdCl2 caused lymphoma in DBA/2NCr mice and local sarcomas in NFS/NCr mice 
(Waalkes and Rehm, 1994). Besides tumors development at target exposed tissues, Cd 
also caused cancers related to estrogen or androgen status, such as breast, prostate, and 
testicular cancers (Waalkes et al., 1999).  
Studies in rats showed that low-level Cd treatment stimulated the growth of 
epithelium in the uterus and mammary glands (Johnson et al., 2003). Since then, Cd 
has been viewed as a xenoestrogen that may stimulate mammary tumor initiation and 
promotion (Schrauzer, 2008; Davis et al., 2013). Ramachandran et al. (2011) reported 
that an oral dose of 1 μg Cd /Kg upregulated luciferase expression in uterus and 
thymus in an estrogen response element-luciferase (ERE-luc) reporter mouse model. 
However, another study conducted in the ERE-luc mice showed that the estrogenic 
effect of Cd was exerted in an ER-independent way. Also, that study did not observe 
the ERE-luciferase activities in any reproductive or non-reproductive organ (Ali et al., 
2010). To deplete endogenous estrogen, a study was conducted in ovariectomized 
Wistar rats (Hofer et al., 2009). In this study, an estrogenic effect was observed in the 
uterus upon intraperitoneal injection of Cd, but not with oral administration.  
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4. Cadmium induced Breast Cancer Initiation and Promotion  
Extrinsic risk factors, such as environmental exposures and behaviors contribute 
to the development of 70 - 90 % cancer cases. The development of cancer is a multi-
step process, including initiation, promotion, and progression (Berenblum and Shubik, 
1947). Fig. 1 shows hallmark events in these three steps. When stimulated by 
carcinogens, normal epithelium transforms to hyperplasic tissue, which initiates 
tumorigenesis. The pre-neoplastic cells grow into a group of dysregulated tumor cells, 
promoting the formation of carcinoma in situ. Eventually, the tumor cells progress into 
metastatic carcinoma, which is an irreversible step. The detailed molecular 
mechanisms have been investigated in different aspects, such as DNA repair 
inhibition, induction of oncogenes, and activation of mitogenic pathways (Bertin and 
Averbeck, 2006; Waisberg et al., 2003).  
Cd is defined as a tumor initiator since it causes DNA lesions in normal cells 
(Potts et al., 2003; Youn et al., 2005). The DNA lesions include DNA strand breaks 
and formation of 8-hydroxyguanine and 8-hydroxy-2'-deoxyguanosine (Dally and 
Hartwig, 1997; Mikhailova et al., 1997). Mechanistic studies revealed that Cd 
inhibited DNA damage repair enzymes, including inhibition of p53, base excision 
repair, nucleotide excision repair, and mismatch repair enzymes, resulting in genome 
instability (Porter et al., 1997; Zharkov and Rosenquist, 2002; Hirano et al., 1997; 
Giaginis et al., 2006). However, Waalkes (2003) pointed out that the direct interaction 
of Cd with DNA and DNA repair enzymes was minimal. Even though high 
concentrations of Cd initiated DNA damage, the high-level exposure was far beyond 
the environmentally relevant concentrations. Benbrahim-Tallaa et al. (2009) found that 
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low-level Cd treatment transformed normal human breast epithelial cells to basal-like 
cells, resulting in tumor formation in vivo. The increase in oncogenes k-ras and c-myc 
in Cd-treated cells further revealed the progress toward invasive cancer phenotype.  
Cd enhances the expressions of several oncogenes, including c-myc, c-jun, and c-
fos which are transcription factors regulating cell growth (Jin and Ringertz, 1990; 
Angel and Karin, 1991; Epner and Herschman, 1991). Cd alters cellular homeostasis 
in various aspects, which may be the mechanism of induction of oncogenes. Cd 
increases reactive oxygen species through inactivating glutathione, which induces the 
expression of oncogenes as a protective mechanism under oxidative stress (Joseph et 
al., 2001). The increase in Ca2+ enhances the response element binding with promoter 
regions for transcription of oncogenes (Hardingham et al., 1997). Alternatively, Cd 
activates cell survival signaling, which stabilizes mRNA of oncogenes (Tsai et al., 
2016).  
Cd has been perceived as a tumor growth promoter in animal studies that are 
described above. Although there is no agreement on the estrogenicity of Cd, it has 
been accepted as a tumor growth stimulant. Most of the in vitro studies reported that 
Cd induced breast cancer cell proliferation (Garcia-Morales et al., 1994; Martin et al., 
2003; Brama et al., 2007; Zang et al., 2009). Garcia-Morales et al (1994) first reported 
that Cd stimulated breast cancer MCF7 cell proliferation and induced transcription of 
ER-regulated genes for cell growth. Thus, the effect of Cd was attributed as an 
estrogenic effect. In our prior work, Cd was found to stimulate triple-negative breast 
cancer cell growth through EGFR-mediated cell cycle progression (Wei et al., 2015). 
Yu et al. (2011) reported that Cd stimulated cell growth via G protein coupled receptor 
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30 in an ERα negative breast cancer cell line SKBR3. Although researchers reported 
that Cd acted as a xenoestrogen since its effects were similar to those of estrogen, 
based on the observation in cells lacking ERα, Cd can also promote cell proliferation 
in an ER-independent manner.  
In summary, Cd has been considered as a weak mutagen in bacterial and yeast 
system (Rossman et al., 1992). It initiates cancer through affecting genome stability 
(Waalkes, 2003). Cd induces disregulation of apoptosis and cell cycle, rendering it the 
properties of a tumor growth promoter. Considering the multistep nature of cancer 
development, Cd may act at all stages of carcinogenesis. It is important to investigate 
the molecular events that contribute to Cd-induced carcinogenesis.  
 
5. Breast cancer progression 
Breast cancer development is a long-term process. It may take years or decades 
for initiated breast tumor to progress into malignant breast cancer. Initiation and 
promotion of breast cancer have been discussed above. This section addresses on 
breast cancer progression, which is the process of tumor cells migrating to distant 
organs and growing into metastases.  
The multiple-step process entails invasion, intravasation and extravasation of 
primary tumor cells, and colonization of metastases (Fig. 1). Adhesion molecules play 
important roles in cancer progression (Okegawa et al., 2004). Cadherin and integrin 
are adhesion molecules on the cell membrane that mediate interaction between cells, 
or with the extracellular matrix (ECM). Epithelial-mesenchymal transition (EMT) is 
the first hallmark of tumor cell movement, which is associated with reduced E-
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cadherin expression (Creighton et al., 2010). The reduced cell-cell adhesion allows 
tumor cells to disseminate from the original site and intravasate into the blood vessels 
and lymph system. When tumor cells are arrested in distant organs, integrins mediate 
adherence to the endothelium of capillary vessel walls. Increased cell-ECM interaction 
allows the cells to extravasate to the new microenvironment. The next sections 
describe the regulation of EMT and elucidate the role of cell adhesion molecules in 
metastatic cell adhesion and growth.  
 
 
Fig. 1. Overview of breast cancer development: initiation, and promotion of primary 
tumor, and progression into metastases. 
 
6. EMT and cancer progression  
EMT is a process in which epithelial cells lose tight junctions and transform to 
mesenchymal-like cells. It is an important step during development and 
embryogenesis (Yang and Weinberg, 2008). Recently, this concept has been extended 
to tumor progression and metastasis, since accumulating evidence in clinical samples 
showed that EMT is associated with advanced stages of cancers (Willipinski-
Stapelfeldt et al., 2005). EMT is associated with a decrease in expression of epithelial 
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markers such as E-cadherin, claudin-1, cytokeratin, and occludin, and an increase in 
mesenchymal markers such as N-cadherin, vimentin, and fibronectin (Sarrio et al., 
2008). Switch to mesenchymal phenotype relates to changed cell morphology and 
enhances motility (Kokkinos et al., 2007). With the enhanced motility, tumor cells 
migrate and metastasize to distant organs. The switch from epithelial to mesenchymal-
like is mediated by key transcription factors, including Snail/Slug, ZEB and Twist. 
Their expression and functions are finely regulated at the translational and post-
translational levels (De Craene and Berx, 2013). 
A number of substances have been identified as EMT inducers. The most potent 
ones are growth factors and cytokines, such as hepatocyte growth factor (HGF), 
epidermal growth factor (EGF), transforming growth factor β (TGFβ), and fibroblast 
growth factor (FGF) (Grotegut et al., 2006; Lo et al., 2007; Shirakihara et al., 2011; 
Patel et al., 2015). Some external factors, such as nicotine, deferoxamine, cyclosporine 
A, chromium, arsenic, and multi-walled carbon nanotube induce the expressions of 
some mesenchymal markers related to EMT (Berzal et al., 2012; Ding et al., 2013; 
Wang et al., 2013; Zhang et al., 2014; Polimeni et al., 2016; Zhang et al., 2016). 
Although Cd has not been reported as an EMT inducer, it decreased E-cadherin 
expression in breast cancer cells and kidney tubular epithelial cells, and increased 
fibronectin expression in lung epithelial cells (Chakraborty et al., 2010a; Chakraborty 
et al., 2010b; Ponce et al., 2015). These observations suggest that treatment with Cd 
may cause EMT in breast cancer cells.  
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6.1 Regulation of EMT markers by transcription factors 
Snail, Twist, and ZEB are transcription factors that regulate the expression of 
EMT markers. They decrease epithelial markers and increase mesenchymal markers 
through transcriptional regulation (Batlle et al., 2000; Cano et al., 2000). Snail directly 
binds to the three E-box regions at CDH1 promoter and functions as a transcription 
suppressor. It also induces histone modification at the CDH1 promoter through the 
recruitment of HDACs (Peinado et al., 2004). HDAC further recruits the histone 
methyltransferase complex to increase histone-specific methylation, thereby activating 
mesenchymal genes such as those encoding vimentin and N-cadherin (Wu et al., 
2011). Similar to Snail, Twist directly binds to E-box regions at CDH1 promoter and 
suppresses E-cadherin transcription (Vesuna et al., 2009; Vesuna et al., 2008). Twist 
also enhances the activity of N-cadherin promoter through binding to the E-box cis-
element in the first intron of the CDH2. Also, the nuclear accumulation of Twist is 
dependent on integrin β1 (Alexander et al., 2006). ZEB cooperates with deacetaylase 
SIRT1 at the CDH1 promoter leading to reduced binding of RNA polymerase II which 
results in suppression of E-cadherin expression (Byles et al., 2012). There is 
increasing interest in deciphering epigenetic modifications at the CDH1 and genome-
wide epigenetic profiling during EMT have been undertaken (McDonald et al., 2011).  
Until now, there is no thorough understanding of the cooperative regulation of 
different EMT transcription factors. Mostly, they are studied individually. 
Nevertheless, knockdown of only one transcription factor is sufficient to partially or 
fully block EMT and metastasis in several cancer cell lines (Murakami et al., 2011).  
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6.2 Regulation of Snail 
Snail plays a critical role in physiologic EMT. Snail knockout mice fail to 
gastrulate because suppressed EMT process leads to an abnormal mesodermal layer 
that maintains E-cadherin expression (Sienel et al., 2003). The expression and function 
of Snail are regulated at transcriptional and post-translational levels (De Craene et al., 
2005; Serrano-Gomez et al., 2016). Activated growth factor receptors and Wnt 
pathway increase Snail transcription, and Wnt/β-catenin signaling stabilizes Snail 
subcellular localization to exert its function (Katoh and Katoh, 2006; Medici et al., 
2008; Zhou et al., 2004).  
Transforming growth factor β (TGFβ) is the best-characterized EMT inducer. It 
binds to TGFβ receptors and activates Smads, and crosstalk with MAPK and PI3K 
pathways (Peinado et al., 2003). In Smad-dependent pathway, activated-Smad 
complex translocates into the nucleus. High-mobility group A2 (HMGA2) integrates 
Smads, TGFβ, MAPK, and PI3K signals and induces Snail transcription (Shirakihara 
et al., 2011). Additionally, induction of hyaluronan synthase 2 (HAS2) by TGFβ 
mediates Snail transcription in a Smad-independent manner (Sullivan et al., 2009).  
Most of Wnt target genes play important roles in EMT (Vincan and Barker, 
2008). Snail transcription is induced by TCF/LEF complex in an axin 2-dependent 
activation of canonical Wnt pathway (Yook et al., 2006). Also, a kinase in Wnt/β -
catenin pathway, GSK3β, regulates Snail degradation. GSK3β phosphorylates Snail at 
two consensus motifs to dually regulate Snail degradation and export from the nucleus 
to the cytoplasm. Inhibition of GSK3β stabilizes Snail in the nucleus where it exerts 
its function (Zhou et al., 2004).  
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7. Cell adhesion network  
Physical interaction of different cells and ECM components are mediated by cell 
adhesion molecules at the cell membrane. The interaction exists in various modes, 
such as coupling of adhesion receptors, convergent signaling or shared signaling 
pathway. Despite the complexity, cell-ECM and cell-cell interactions together perform 
a simple role, connecting the internal cytoskeleton to cell exterior and maintaining 
tissue integrity. This role is carried out mainly by two groups of cell adhesion 
molecules, cadherin, and integrin (Weber et al., 2011). 
 
7.1 Cell-cell interaction - cadherin  
Cell-cell adhesion is critical in maintaining tissue integrity. It supports cell 
communications through physical contacts. Cadherins are Ca2+ dependent 
glycoproteins, which serve as the primary molecule in cell-cell adhesion, and play a 
role in tissue differentiation. The most studied are E- and N-cadherins (Takeichi et al., 
1990a). In epithelial cells, E-cadherins are abundantly expressed at adherent junctions 
to hold epithelial sheets together (Takeichi et al., 1990b). The amount of cadherins 
affects cell-cell adhesion and individual cell movement. Alteration in E-cadherin 
indicates either tissue differentiation or disease. Chen et al. (2012) demonstrated that  
loss of E-cadherin promoted colorectal cancer metastasis.  
E-Cadherin not only functions as a structural protein at the adhering junction, but 
is also involved in Wnt/β-catenin pathway (Thievessen et al., 2003). The cytosol 
domain of E-cadherin attaches to β-catenin, which is the most important molecule in 
Wnt/β-catenin pathway. Disruption of E-cadherin triggers the release of β-catenin. 
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Increasing nuclear translocation of β-catenin activates Wnt-responsive genes, which 
foster carcinogenesis (Prange et al., 2003). 
 
7.2 Cell-ECM interaction and role of integrins  
Integrins are transmembrane glycoprotein receptors that mediate cell-ECM 
interaction. They form heterodimers in different combinations of α and β subunits. 
Integrins mediate anchorage and migration of cells via recognition of variable ECM 
molecules and other ligands. The cytoplasmic tail of integrin associates with scaffold 
proteins. At the focal adhesion site, the scaffold proteins talin and vinculin provide a 
hub for kinases recruitment and linkage to actin filaments (Legate et al., 2009).  
The activation of kinases at focal adhesion site is an important downstream 
signaling of integrin-mediated cell-ECM interaction (Huveneers and Danen, 2009). 
When integrins encounter ECM or other ligands, focal adhesion kinase (FAK) is 
autophosphorylated at Tyr 397 site. It provided a binding site for Src and activates it at 
Tyr 416 site. In turn, Src phosphorylates other tyrosine residues of FAK (Brunton et 
al., 2005). The FAK/Src complex maximizes the adhesion signaling to induce the 
assembly of focal adhesion. FAK/Src complex further recruits and phosphorylates 
other adhesion proteins, like paxillin, and potentially controls Rho/Rac activation, 
which directly regulates polymerization of microtubules. The spatiotemporal 
activation of focal adhesion kinase determines cell adhesion, membrane protrusion and 
further modulates cell motility (Ohta et al., 2006). In addition, activated integrin-
signaling crosstalk with mitogenic pathways, stimulating cells growth (Vial et al., 
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2003). Cell adhesion, migration, and proliferation are key factors in the formation of 
secondary tumor at distant organs. 
Treatment with low concentrations of Cd stimulated actin filament formation in 
lung epithelial cells (Go et al., 2013). Choong et al. (2013) described that Cd induced 
the phosphorylation of FAK (Tyr 397/Tyr 975), and Src (Tyr 416) in rat mesangial 
cells. These phosphorylation patterns iSndicate that Cd affects FAK-Src complex. 
This complex is an important regulatory complex in focal adhesion site, which is 
downstream of integrin signaling. It is possible that Cd interferes with membrane 
integrin and alters cytoskeleton for cell migration. 
 
Summary 
Many in vitro studies have illustrated how low concentrations of Cd contribute to 
breast cancer initiation and promotion. Nevertheless, few studies address its effect on 
cancer progression. Cd may accelerate breast cancer progression to fulfill the role as a 
carcinogen, which is aligned with our current understanding in cancer biology.  
The concept of EMT has emphasized the importance of plastic changes in tumor 
cell migration. Integrins and ECM interaction further facilitates metastasized cancer 
cell adhesion and growth. Investigating the effects of Cd on EMT and integrin will 
help illustrate the role of Cd in cell adhesion and migration. This dissertation reports 
the results of such an investigation in Chapters 2 and 3. 
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Abstract 
Epidemiological and experimental studies have implicated cadmium (Cd) in 
breast cancer development. Cancer initiation and promotion have been described 
previously. The present study examined cancer progression upon Cd treatment. 
Specifically, it examined whether Cd treatment causes epithelial-mesenchymal 
transition (EMT), a hallmark of cancer progression. Four human breast epithelial cell 
lines, consisting of non-cancerous MCF10A, non-metastatic HCC 1937 and HCC 38, 
and metastatic MDA-MB-231 were treated with 1 or 3 μM Cd for 4 weeks. Among 
these prolonged Cd-treated epithelial cells, MCF10A cells showed different 
morphology, which was accompanied with the increased expression of E-cadherin and 
a decreased of N-cadherin at cell boarders. Furthermore, the Cd-treated cells exhibited 
an increase in vimentin, and a decrease in claudin-1 level. These changes in EMT 
markers indicate that Cd caused EMT. MCF10A and MDA-MB-231 cells labeled with 
Zcad, a dual sensor for tracking EMT, demonstrated a decrease in the epithelial 
marker E-cadherin, and an increase in a mesenchymal marker ZEB-1. In order to 
further explore the mechanism of Cd-induced EMT, Snail, which is a transcription 
factor involved in regulating EMT, was investigated. The results revealed an increase 
in Snail level in the nucleus. Inhibition of transcription by actinomycin D eliminated 
the Cd-induced Snail accumulation. However, inhibition of nuclear export by 
leptomycin B had an additive effect on Cd-induced Snail expression. Based on these 
results, it appears that Cd induces EMT in breast epithelial cells by modulating the 
transcription of Snail. 
Keywords: Cadmium, Epithelial-mesenchymal transition, Snail. 
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Highlights 
• Prolonged Cd treatment induces EMT in breast epithelial cells. 
• The EMT is associated with accumulation of Snail in the nucleus. 
• Cd affects Snail expression and regulates the post-transcriptional activity of 
ZEB-1 
 
Introduction 
Cadmium (Cd) is an environmental pollutant and a well-established human health 
risk. Epidemiological and experimental studies have established its carcinogenic 
potential (Waalkes et al., 1994; Adams et al., 2012). The International Agency for 
Research on Cancer has categorized Cd as a group 1B carcinogen. Waisberg et al. 
(2003) summarized studies implicating Cd in breast cancer initiation and promotion. 
As the second leading cancer in women, most breast cancer deaths are due to tumor 
progression into advanced stages (Siegel et al., 2016). Therefore, investigating 
environmental factors that could potentially contribute to breast cancer progression 
provides insight into breast cancer prevention. The study described herein aims to 
further investigate the effect of Cd on breast cancer progression. 
Progression of a tumor in situ to an invasive phenotype requires an increase in 
tumor cell plasticity (Park et al., 2010). EMT is a hallmark of increased cell plasticity 
and has been associated with invasive breast cancer progression (Fuchs et al., 2002). 
EMT is marked by the loss of epithelial markers such as E-cadherin and claudin-1, and 
the gain of mesenchymal markers such as N-cadherin, fibronectin and vimentin 
(Willipinski-Stapelfeldt et al., 2005). Treatment with Cd has been reported to induce 
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expressions of two mesenchymal markers such as vimentin, and fibronectin in kidneys 
of mice and in lung epithelial (Chakraborty et al., 2010; Person et al., 2013). Results 
reported by Ponce et al. (2015) showed that E-cadherin expression was downregulated 
in MCF7 cells treated with Cd for six months. Benbrahim-Tallaa et al. (2009) reported 
transformation of the normal breast epithelial MCF10A cells to a basal-like cancer 
phenotype upon treatment with Cd for 40 weeks. Thus, Cd appears to induce EMT, the 
mechanism remains to be elucidated.  
EMT is a continuous process of epithelial cells transforming into motile 
mesenchymal cells. There are several transcription factors that regulate the expression 
of EMT markers. Snail is one such marker and is a zinc-finger transcription factor, it 
represses E-cadherin expression through binding to the three E-box consensus 
sequences at CDH1 promoter region (Batlle et al., 2000; Cano et al., 2000; Peinado et 
al., 2004). Similarly, zinc-finger E-box-binding homeobox (ZEB) binds to E-boxes 
and suppresses E-cadherin expression through cooperation with co-repressors (Postigo 
et al., 2003; Sanchez-Tillo et al., 2010). Thus, it is important to assess the effect of Cd 
on the expressions of Snail and ZEB. 
The study described herein investigated the process of EMT in normal and breast 
cancer cells upon treatment with Cd.  
 
Materials and Methods 
Materials  
MEGM, DMEM, RPMI 1640, and trypsin-versene were purchased from Lonza 
(Walkersville, MD). Fetal bovine serum (FBS) was purchased from Atlanta 
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Biologicals (Flowery Branch, GA). CdCl2, PMSF, and protease inhibitor were 
purchased from Sigma-Aldrich (Dallas, TX). Bis-acrylamide powder, suspersignal 
west femto maximum sensitivity substrate, and BCA kit were purchased from 
Thermo-Fisher Scientiﬁc (Pittsburgh, PA). Phosphatase inhibitor cocktail tablets were 
purchased from Roche (Indianapolis, IN). Laemmli buffer and blotting buffers were 
obtained from Bio-Rad (Hercules, CA). Actinomycin D (ACD) and leptomycin B 
(LMB) was purchased from Cayman Chemical (Ann Arbor, Michigan). Primary 
antibodies in epithelial-mesenchymal transition kit, lamin A/C, and HRP-conjugated 
secondary antibody were from Cell Signaling Technology (Danvers, MA). GAPDH 
primary antibody and slide chamber were purchased from EMD Millipore (Billerica, 
MA). CF5.5 goat anti-rabbit IgG was purchased from Santa Cruz Biotechnology 
(Dallas, TX). IRDye 680 goat anti-rabbit and goat anti-mouse IgG antibodies were 
purchased from Licor (Lincoln, NE). Nuclear Extract Kit was purchased from Active 
Motif (Carlsbad, CA).  
 
Cell lines and cell culture 
MCF10A, MDA-MB-231, HCC 1937 and HCC 38 cell lines were obtained from 
American Type Culture Collection (Manassas, VA). MCF10A-Zcad and MDA-MB-
231-Zcad cells stably transfected with the Zcad sensor were generously provided by 
Dr. Jeffery Rosen of Baylor College of Medicine. The MCF10A and MCF10A-Zcad 
cells were cultured in MEGM containing insulin, hydrocortisone, and EGF. MDA-
MB-231 and MDA-MB-231-Zcad cells were cultured in DMEM supplemented with 
10% FBS and penicillin (100 U/mL)/streptomycin (100 U/mL). HCC 1937 and HCC 
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38 were cultured in RPMI 1640 supplemented with 10% FBS and penicillin (100 
U/mL)/streptomycin (100 U/mL). Cells undergoing prolonged Cd treatment were 
maintained in corresponding medium for 4 weeks. The cells were maintained in a 
humidified incubator (37°C) with 5% CO2. Cell morphology was observed under a 
Nikon phase contrast microscope.  
 
Immuno-fluoresce staining  
Control and Cd-treated MCF10A cells were seeded in slide chambers in MEGM. 
For specimen preparation, cells were fixed by treatment with 4% paraformaldehyde in 
PBS for 15 min followed by permeation with 0.3% Triton X-100 in 1% BSA-
supplemented PBS. Cells were then blocked in 5% BSA-supplemented PBS. Finally, 
cells were incubated with primary antibody for E- or N-cadherin overnight. After 
washing with PBS for 5 min, three times, cells were stained using secondary antibody 
CF5.5 goat anti-rabbit IgG. Nuclei were stained with DAPI. Images of the stained 
cells were taken with a Nikon NE2000 fluorescence microscope and processed using 
NIS Elements acquisition software. 
 
Evaluation of Zcad expression  
MCF10A-Zcad and MDA-MB-231-Zcad cells were seeded in 6-well plates and 
cultured in MEGM or DMEM, respectively. Evaluation of E-cadherin expression and 
ZEB-1 activity in Cd- or TGFβ-treated Zcad cells was performed using a BD 
FACSVerse. The intensities of RFP and GFP were analyzed in FITC and PE channels, 
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respectively. Quantification of cells expressing E-cadherin or ZEB-1 was performed 
by measuring the relative change in RFP or GFP intensities.  
 
Western blot 
Whole cell lysates were prepared in RIPA buffer. Nuclear and cytoplasmic 
fractions were prepared using an Active Motif nuclear extraction kit. Protein 
concentration in cell lysates was determined using the BCA kit. Proteins were 
denatured by heating the lysate to 95°C in Laemmli buffer containing 5% β-
mercaptoethanol. Proteins in the samples were then separated by SDS-PAGE 
electrophoresis and transferred to nitrocellulose membranes. The membranes were 
incubated with 5% non-fat milk for 1 h followed by incubation with the primary 
antibody overnight. The membranes were rinsed in PBS containing 0.5% Tween 20, 
for 5 min, three times, and incubated with the IRDye or HRP-conjugated secondary 
antibody for 1 h. Following incubation, the membranes received three washings in 
PBS containing 0.5% Tween 20 and scanned in a Licor Odyssey Imager. The optical 
densities of protein bands were quantiﬁed by Odyssey Image Analysis Software. 
 
Data analysis 
All experiments were repeated at least three times. One-way ANOVA was 
performed by Prism with Tukey’s post hoc test, and p<0.05 was considered 
statistically significant. 
 
Results 
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Cell morphology and expressions of cadherins  
Treatment with 1 μM Cd for 4 weeks transformed the morphology of normal 
breast epithelial cells (Fig. 1). The untreated MCF10A cells displayed regular 
epithelial sheets, indicating tight cell-cell adhesion. In contrast, cells treated with Cd 
appeared spindle-like and had reduced intercellular adhesion.  
Intracellular adhesion is mediated through cadherins. Thus, cells were stained for 
E- and N-cadherin, respectively. The immunofluorescence pattern indicated the 
expression and location of cadherins. As shown in Fig. 2, the normal MCF10A cells 
displayed strong E-cadherin, but faint and diffuse N-cadherin expression in the 
cytoplasm. Treatment with 1 μM Cd for 4 weeks significantly changed the 
fluorescence pattern of cadherins. In most Cd-treated cells, less E-cadherin (epithelial 
marker) was visible, but N-cadherin (mesenchymal marker) was apparent at well-
defined cell borders. Overall, these morphological and phenotypical changes indicated 
that prolonged Cd treatment transformed the breast epithelial MCF10A cells to a more 
mesenchymal-like phenotype.  
 
Expressions of EMT markers  
To further examine the EMT, four human breast epithelial cell lines, consisting of 
normal MCF10A, non-metastatic HCC 38 and HCC 1937, and metastatic MDA-MB-
231 were treated with 1 or 3 μM Cd for 4 weeks. As shown in Fig. 3, in MCF10A 
cells, treatment with 1 μM Cd reduced the expression of E-cadherin 84% and 
increased the expression of N-cadherin and vimentin 1.6- and 2.6-fold, respectively. 
Although MDA-MB-231 cells expressed very low level of both E- and N-cadherin 
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(Blick et al., 2008), their expression of vimentin was upregulated 5.1-fold (Fig 3). In 
HCC 1937 cells, treatment with 3 μM Cd decreased E-cadherin and claudin-1 
expression 55 and 63%, respectively.  The HCC 38 cells expressed high basal levels of 
E- and N-cadherins. In these cells, the Cd-induced reduction in E-cadherin was not 
statistically significant, but claudin-1 level was reduced 59%, and the expression of N-
cadherin was enhanced 2.7-fold over the control cells. Thus, in all four types of breast 
epithelial cells, generally, prolonged Cd treatment caused an increase in mesenchymal 
markers and a decrease in epithelial markers, further confirming its effect on EMT. 
 
Further confirmation of EMT by Zcad sensor 
Transition of epithelial to mesenchymal-like phenotype is a gradual process. 
Thus, to track the change in expressions of E-cadherin and its transcription suppressor 
ZEB-1, the Zcad sensor was utilized. The Zcad sensor is comprised of an Ecad-RFP 
plasmid containing RFP driven by the CDH1 promoter, and the ZEB-GFP plasmid 
containing destabilized GFP indicates ZEB-1 translation (Toneff et al., 2016). 
Therefore, RFP intensity measures E-cadherin expression, and GFP intensity indicates 
ZEB-1 expression. Stably transfected MCF10A and MDA-MB-231 cells were treated 
with Cd or TGFβ for up to 4 weeks. As expected, the TGFβ-treated MCF10A-Zcad 
cells expressed less E-cadherin as indicated by a marked reduction (45%) in RFP 
intensity in UL area than the control cells after 4 weeks of treatment. Similar, but less 
pronounced effect was observed in the 1 μM Cd-treated cells which was a 13% 
decrease in RFP intensity in UL area (Fig. 4A). The MDA-MB-231-Zcad cells which 
had higher ZEB-1 activity, showed strong GFP intensity. As shown in Fig. 4B, 
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treatment with 3 μM Cd for 4 weeks caused a 1.7-fold increase in GFP intensity (LR 
area) in the MDA-MB-231-Zcad cells. The positive control, TGFβ caused a 3.7-fold 
increase. The increase in GFP expression in Zcad cells indicated enhanced translation 
of ZEB-1. ZEB-1 is a direct E-cadherin transcription suppressor (Sanchez-Tillo et al., 
2010). Enhanced ZEB-1 activity predicts a more mesenchymal-like property, and 
indicates that Cd treatment suppress the transcription of E-cadherin.  
 
Expression of transcription factor Snail 
Snail primarily functions as an EMT regulator (Peinado et al., 2007). When HCC 
1937, HCC 38, and MDA-MB-231 cells were treated with 3 μM Cd for 4 weeks, the 
Snail levels were increased 3.5-, 3.4-, and 2.1-fold in these cells, respectively (Fig. 5).  
Snail is formed in cytosol and imported to nucleus to exert its function. Therefore, 
the distribution of Snail in these compartments following Cd treatment was analyzed 
in the HCC 1937 and HCC 38 cells after treatment with 3 μM for 4 weeks. As shown 
in Fig. 6, the Snail expression was barely detectable in the cytosol. However, in the 
nuclear fraction of HCC 1937 and HCC 38 cells, there was a 2.5- and 3.4-fold 
increase, respectively, in Snail levels as compared to the control cells. Therefore, Snail 
accumulation in the nucleus indicates that the breast cancer cells undergo Snail-
mediated EMT upon prolonged Cd treatment. 
 
Time-course of Snail expression  
The HCC 1937 and HCC 38 cells were treated with 1 μM Cd for up to 8 h and 
Snail levels were determined in the whole cell extract. As shown in Fig. 7A, the Snail 
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expression was gradually upregulated to 3-fold during 8 h of treatment with 1 μM Cd. 
To evaluate whether the upregulation was due to increased transcription, ACD, a 
transcription inhibitor, was used as a co-treatment with 1 μM Cd for 8 h. Treatment 
with TGFβ served as positive control. In the absence of ACD, Cd and TGFβ 
treatments resulted in a 2.1- and 2.4-fold increase in Snail expression, respectively 
(Fig. 7B). Co-treatment with ACD completely abolished this effect. This finding 
indicates that Snail accumulation in the nucleus could be through the increase in 
transcription. 
The half-life of Snail is 30 min. Snail is exported from the nucleus into the 
cytoplasm where it is degraded by proteasomes (Zhou et al., 2004). Therefore, Snail 
accumulation in the nucleus could also be due to inhibition of nuclear export. To 
further evaluate this possibility, the HCC 1937 cells were treated with Cd and LMB, a 
nuclear export inhibitor. As shown in Fig. 8, while Cd and LMB treatments 
individually resulted in a 2.7- and 2.5-fold Snail expression, respectively. The co-
treatment had an additive effect in Snail expression. This finding further indicates that 
Cd regulates the expression of Snail in a transcriptional-related manner, and not by 
inhibition of its nuclear export. 
 
Discussion 
Prozialeck’s group reported that Cd reduced E-cadherin expression at cell 
membrane in kidney tubular cells, causing cell-cell dissemination (Prozialeck and 
Niewenhuis, 1991; Prozialeck and Lamar, 1997; Zimmerhackl et al., 1998; Prozialeck, 
2000; Prozialeck et al., 2003). The loss of E-cadherin expression in breast and prostate 
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carcinomas is correlated with tumor aggressiveness and metastasis (Umbas et al., 
1992; Morita et al., 1999; Kowalski et al., 2003; Jeschke et al., 2007). In the present 
study, E-cadherin level was suppressed upon prolonged Cd treatment in breast 
epithelial cells. Such alteration was attributed to EMT based on the following 
observations.  
The primary key finding in the present study is that prolonged treatment of Cd 
changes the expression of epithelial and mesenchymal markers E- and N-cadherins, 
vimentin, and claudin-1. These markers are hallmarks of EMT (De Craene and Berx, 
2013). The initiation or enhancement of EMT was not restricted to the stage of cancer 
cells and occurred in normal MCF10A cells, non-metastatic HCC 1937 and HCC 38 
cells, and metastatic MDA-MB-231 cells (Fig. 3). Furthermore, In Zcad transfected 
cells, expressions of RFP and GFP represented expression of E-cadherin and ZEB-1, 
respectively. MCF10A-Zcad and MDA-MB-231-Zcad cells exhibited a decrease in 
RFP and increase in GFP intensities upon Cd treatment, indicating suppression of E-
cadherin transcription and active ZEB-1 translation (Fig. 4).  
The use of Zcad cells also revealed related mechanism in Cd-induced EMT. Zcad 
is a dual fluorescence sensor which consists of ZEB-GFP and Ecad-RFP plasmids. 
According to the construct sequence provided by Toneff et al. (2016), ZEB-GFP 
plasmid is designed based on the knowledge that ZEB is suppressed by the miR-200 
family (Burk et al., 2008; Korpal et al., 2008). This plasmid contains eight miR-200 
binding sites in ZEB-1 3’ UTR region which is downstream of UbC and GFP. Thus, 
constitutive GFP expression indicates less binding of miR-200 in ZEB-1 3’ UTR 
region, suggesting active ZEB-1 translation. In the present study, the increase in GFP 
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intensity in MDA-MB-231-Zcad cells suggested that less miR-200 was bond to ZEB-1 
3’ UTR region upon 4 weeks of Cd treatment. It is possible that Cd inhibits miR-200 
that post-transcriptionally suppresses ZEB-1 translation, as speculated in Fig. 9. ZEB-
1 is a transcription suppressor of E-cadherin (Gregory et al., 2008; Sanchez-Tillo et 
al., 2010). Therefore, prolonged Cd treatment appears to stabilize GFP (Fig. 4B), 
suggesting a potential mechanism of regulation of EMT in a post-transcriptional 
manner. 
Beside the ZEB-GFP plasmid, the Ecad-RFP plasmid measures transcription 
activity at CDH1 promoter region. The decrease in RFP intensity indicated that Cd 
suppressed E-cadherin transcription (Fig. 4A). Snail represses CDH1 transcription 
through binding to the E-box in the promoter region of CDH1 (Batlle et al., 2000; 
Cano et al., 2000). The observation that Snail accumulated in the nucleus upon Cd 
treatment (Fig. 6) was consistent with the results showing reduced RFP in MCF10A-
Zcad cells (Fig. 4A). It appears that Cd treatment affects the expression of 
transcription factors that regulate EMT. 
The secondary key finding is that Cd increased the expression of Snail. Prolonged 
Cd treatment resulted in Snail accumulation in the nucleus, which explained the EMT 
upon 4 weeks of Cd treatment (Fig. 5 and Fig. 6). Also, treatment of cells with 1 μM 
Cd for 4 - 8 h resulted in an increase in Snail expression (Fig. 7A), which was 
abolished by inhibition of transcription by ACD (Fig. 7B). These results suggest that 
transcriptional activity is crucial for Cd-induced Snail expression. Cd and nuclear 
export inhibitor LMB additively increased Snail expression (Fig. 8). LMB prevented 
Snail export from the nucleus and resulted in Snail accumulation. Cd-induced Snail 
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transcription and not inhibition of its export is likely the reason of additive effect upon 
co-treatment with LMB.  
TGFβ and receptor tyrosine kinase signaling pathways crosstalk and converge to 
regulate the transcription of Snail (Yook et al., 2005; Horiguchi et al., 2012). To 
maintain the homeostasis of Snail expression, GSK3β phosphorylates Snail and 
prepares it for degradation by proteasomes (Zhou et al., 2004). Baroni et al. (2015) 
reported that treatment of bronchial epithelial cells with Cd affected TGFβ pathway. 
Based on this report, it is possible that Cd upregulates Snail transcription through the 
TGFβ pathway. Cd treatment activates Wnt/β-catenin pathway and inhibits GSK3β in 
metastasized breast cancer cells (unpublished data). Thus, it is possible that Cd could 
also decrease Snail degradation.  
The progression of breast cancer to a more advanced stage involves the transition 
of hyperplastic epithelial tissue toward a metastatic carcinoma. EMT is a critical event 
in this process (Thiery, 2002). The biochemical changes that occur in EMT render the 
tumor cells more invasive phenotypes, which help the cells to migrate through the 
basement membrane into the circulation to distant tissues and organs (Trimboli et al., 
2008). The study reported here is the first showing induction of EMT in normal and 
breast cancer cells upon Cd treatment. Besides the use of non-cancerous breast 
epithelial cell line MCF10A which is a well-accepted model to study EMT (Sarrio et 
al., 2008), the results in non-metastatic and metastatic cancer cell lines indicate that 
Cd not only induces, but also enhances EMT.  
Although the detailed mechanism of Cd-induced Snail expression remains to be 
further elucidated, based on the results of this study, it is concluded that Cd treatment 
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upregulates Snail expression, substantially transforming epithelium-derived breast 
cancer cells to a more mesenchymal-like phenotype. The present study also suggests 
that Cd affects transcription of Snail and post-transcriptional activity of ZEB-1, which 
are two well-known biochemical mechanisms in the regulation of EMT.  
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Figures 
 
Control                   Cd-treated 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Changes in morphology of MCF10A cells upon prolonged Cd treatment. 
The cells were treated with 1 μM Cd in MEGM for 4 weeks. Control cells were 
cultured in MEGM alone. Phase contrast images of the cultured cells were taken under 
4X and 10X objective lenses.  
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Fig. 2. Expression of cadherins in MCF10A cells upon prolonged Cd treatment. 
The cells were treated with 1 μM Cd in MEGM for 4 weeks. Control cells were 
cultured in MEGM. The cells were fixed and stained to visualize the abundance of E-
cadherin and N-cadherin. Nuclei were stained with DAPI. The immuno-fluorescence 
images were taken under a 20X objective lens. Relative intensity of red fluorescence 
indicated cadherin levels. 
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Fig. 3. Expressions of EMT markers upon prolonged Cd treatment. 
MCF10A cells were treated with 1 μM Cd for 4 weeks in MEGM. MDA-MB-231, 
HCC 1937, and HCC 38 cells were treated with 3 μM Cd for 4 weeks in DMEM or 
RPMI 1640 supplemented with 10 % FBS. Representative Western blots are shown. 
Densities relative to the control group are plotted as mean±SEM (n=3). *Significantly 
different from the respective control group (p < 0.05). 
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Fig. 4. Time-course of EMT upon prolonged Cd treatment. 
(A) E-cadherin expression in MCF10A-Zcad cells. The cells were seeded in MEGM 
and treated with MEGM containing 1 μM Cd or 10 ng/ml TGFβ for up to 4 weeks. 
Cells were harvested every week and analyzed by flow cytometry. Representative dot 
plots of the distribution of cells expressing RFP are shown. Cells expressing E-
cadherin (RFP) were in the upper left (UL) quadrant. (B) ZEB-1 activity in MDA-
MB-231-Zcad cells. The cells were seeded in DMEM supplemented with 10% FBS 
and treated with 3 μM Cd or 10 ng/ml TGFβ for up to 4 weeks. Cells were harvested 
every week and analyzed by flow cytometry. Representative dot plots of the 
distribution of cells expressing ZEB-1 (GFP) are shown. Cells expressing ZEB-1 are 
in the lower right (LR) quadrant. Data from three independent experiments are plotted 
as mean±SEM (n=3). *Significantly different from the control group at the same time 
point (p < 0.05). 
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Fig. 5. Expression of Snail upon prolonged Cd treatment. 
HCC 1937, HCC 38, and MDA-MB-231 cells were treated with 3 μM for 4 weeks in 
RPMI 1640 or DMEM supplemented with 10 % FBS. Representative Western blots of 
the expression of Snail are shown. Densities relative to the control group are plotted as 
mean±SEM (n=3). *Significantly higher than the respective control group (p < 0.05). 
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Fig. 6. Intracellular distribution of Snail upon prolonged Cd treatment. 
HCC 1937 and HCC 38 cells were treated with 3 μM Cd for 4 weeks in RPMI 1640 or 
DMEM supplemented with 10 % FBS. Representative Western blots of the expression 
of Snail in whole cell lysate, cytosolic, and nuclear fractions are shown. Densities 
relative to the control group are plotted as mean±SEM (n=3). *Significantly higher 
than the respective control group (p < 0.05). 
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Fig. 7. Time-course of Snail expression.  
(A) Time-course of Snail expression in HCC 1937 cells. The cells were treated with 1 
µM Cd in the RPMI 1640 for up to 8 h and cell lysates were analyzed for Snail 
expression. Representative Western blot of Snail expression is shown. Densities 
relative to the control group are plotted as mean±SEM (n=3). (B) Inhibition of Snail 
transcription in HCC 1937 cells. The cells were treated with 1 µM Cd or 10 ng/ml 
TGFβ in the absence or presence of 10 nM ACD for 8 h. Representative Western blot 
of Snail expression is shown. Densities relative to the control group are plotted as 
mean±SEM (n=3). *Significantly higher than the control group (p < 0.05).  
#Significantly higher than the respective ACD treated group (p < 0.05). 
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Fig. 8 Inhibition of nuclear Snail transport by LMB.  
HCC 1937 cells were treated with 1 µM Cd in the presence or absence of 20 ng/ml 
LMB for 1, 4, or 8 h. Representative Western blots of Snail expression are shown. 
Densities relative to the respective control group at 1 h are plotted as mean±SEM 
(n=3). *Significantly different from the control group (p < 0.05). 
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Fig. 9 Schematic diagram summarizing the effect of Cd treatment on the regulation of 
EMT. 
(A) Cd treatment increases the expression of Snail, resulting in suppression of E-
cadherin expression. Decrease in RFP indicates suppression of E-cadherin 
transcription, which is in concord with the upregulation of Snail. 
(B) Increase in GFP indicates less miR-200 binding. Cd treatment may suppress miR-
200 expression or inhibit miR-200 binding in ZEB-1 3’UTR region.
(A) 
(B) 
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Abstract 
Cadmium (Cd) is a carcinogenic heavy metal which is implicated in breast cancer 
development. While the mechanisms of Cd-induced breast cancer initiation and 
promotion have been well studied, but the molecular processes involved in breast 
cancer progression are not. The purpose of the present study was to evaluate the 
influence of Cd on metastasis-associated phenotypes, such as cell adhesion, migration, 
and invasion by using MDA-MB-231 cells. Treatment with 1 or 3 μM Cd for 1-6 h 
increased cell spreading and migration. This observation was found to be associated 
with integrin signaling since the activation of integrin β1, FAK, Src, and Rac1. The 
treatment with 1 or 3 μM Cd also inhibited GSK3β activity and induced T-cell 
factor/lymphoid enhancer factor (TCF/LEF) transcription, indicating the involvement 
of β-catenin signaling. Furthermore, treatment with 3 μM Cd for 4 weeks increased the 
expression of β-catenin and enhanced TCF/LEF transcription. Also, the enhanced 
expressions of integrin α5 and β1, paxillin, and vimentin indicated that prolonged Cd 
treatment reorganized the cytoskeleton, which aided malignancy, as evidenced by 
enhanced matrix metalloprotease 2/9 (MMP2/9) secretion and cell invasion. In 
addition, prolonged Cd treatment caused an increase in cell growth rate. Together, 
these results indicate that Cd alters key signaling processes involved in the regulation 
of cytoskeleton to enhance cancer cell migration, invasion, adhesion, and proliferation.  
 
Key words: Cadmium, metastasis, integrin, β-catenin 
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Highlights 
• Cd treatment enhances cell adhesion and spreading in breast cancer cells 
through integrin activation. 
• Inhibition of GSK3β by Cd leads to activation of Wnt/β-catenin pathway. 
• Accumulation of β-catenin facilitates TCF/LEF transcription. 
• Acquisitions of metastasis-associated phenotypes increases cell migration, 
invasion, and proliferation. 
 
Introduction 
Cadmium (Cd) is a toxic heavy metal and exposure to this metal has been 
associated with development in lung, kidney, prostate, and breast cancer (Stayner et 
al., 1992; Il'yasova and Schwartz, 2005; Sahmoun et al., 2005; Julin et al., 2012a; 
Julin et al., 2012b). Studies in mice and rats have confirmed that Cd treatment results 
in the development of lung, breast, and bladder cancer (Takenaka et al., 1983; 
Shiraishi et al., 1994; Johnson et al., 2003; Schrauzer, 2008; Davis et al., 2013). The 
International Agency for Research on Cancer has categorized Cd as a Group 1B 
carcinogen. Carcinogenesis is a continuous process comprised of initiation, promotion, 
and progression. Promotion of cell growth by Cd treatment is described as a 
xenoestrogenic effect (Siewit et al., 2010; Ponce et al., 2013; Song et al., 2015), 
involving membrane receptors (Yu et al., 2010; Wei et al., 2015).  
A number of studies indicate that Cd initiates and promotes breast cancer 
development, with some suggesting that it also promotes breast cancer metastasis 
(Yang et al., 2004; Benbrahim-Tallaa et al., 2009; Siewit et al., 2010). Waalkes et al. 
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(2000) reported that chronic Cd exposure increased the metastatic potential of 
subcutaneously-injected sarcomas in rats. Metastasis is a multi-step process that 
includes dissemination, migration, intravasation, extravasation, and colonization to 
form secondary tumors. Specific mechanisms underlying these elements upon Cd 
treatment are poorly understood. Results reported by Ponce et al. (2015) suggested 
that Cd interfered with cell-cell interaction by disrupting E-cadherin, enhancing the 
ability of breast cancer cells to disseminate from the primary tumor. 
After disseminating from primary tumors, metastatic breast cancer cells enter a 
prolonged period of latency before forming secondary tumors. The rate-limiting steps 
seem to be extravasation and cell proliferation (Luzzi et al., 1998). During 
extravasation, metastatic cancer cells migrate through endothelial barriers and settle in 
new microenvironments via cell adhesion molecules (Felding-Habermann et al., 
2001). An important feature in metastatic cell movement is alteration of cellular 
microfilament dynamics and extracellular matrix (ECM) remodeling. Integrin adheres 
to ECM proteins and alters cytoskeletal dynamics, leading to cell adhesion and 
migration. FAK-Src complex transduces integrin signaling to downstream Rac/Rho, 
which initiates assembly of microfilaments (Mitra and Schlaepfer, 2006). Crosstalk 
with PI3K and MAPK promotes cell survival and proliferation (Giancotti and 
Ruoslahti, 1999). In lung epithelial cells, 0.5 and 1 μM Cd stimulated actin filament 
formation (Go et al., 2013). Baroni et al. (2015) reported that 10 μM Cd increased 
integrin β1 and β5 gene expression and directly affected the production of ECM 
proteins in human bronchial epithelial cells. Accordingly, it seems reasonable to 
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hypothesize that Cd affects metastasized breast cancer cell adhesion through 
alterations in integrin activation. 
Colonization at metastasized sites requires cells to proliferate to counterbalance 
cell death. Activation of the Wnt/β-catenin pathway, that normally regulates cell 
proliferation during embryonic development, has been implicated in tumorigenesis in 
colon cancer, leukemia, and breast cancer (Reya and Clevers, 2005). The Wnt 
pathway is initiated after Wnt ligands bind to Frizzled and Lrp 5/6 receptors. Receptor 
occupancy leads to accumulation of an important downstream signaling protein, β-
catenin. As a consequence of GSK3β-mediated phosphorylation, β-catenin 
translocates into the nucleus and forms co-transcriptional activators with TCF/LEF, 
driving transcription of many oncogenes (Eastman and Grosschedl, 1999). Mice 
exposed to Cd increased release of Wnt ligand and transcription of Wnt receptors 
(Chakraborty et al., 2010b). The same group (Chakraborty et al., 2010a) reported that 
Cd enhanced nuclear translocation of β-catenin, which triggered TCF/LEF-mediated 
transcription in human kidney tubular cells. In addition, Cd increased free β-catenin 
accumulation through disruption of cadherins (Edwards et al., 2013). Based on these 
studies conducted in mouse or human kidney cells, Cd may stimulate secondary tumor 
growth through activation of Wnt/β-catenin-dependent pathways.  
In summary, cellular migration and metastasis involve increased ECM 
interaction, activated adhesion-related signaling, crosstalk with β-catenin and 
mitogenic signaling. Thus, the present study focuses on these processes to test the 
hypothesis that Cd exerts carcinogenic effects on breast cancer progression. 
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Materials and Methods 
Materials  
DMEM and trypsin-versene were purchased from Lonza (Walkersville, MD). 
Fetal bovine serum (FBS) was purchased from Atlanta Biologicals (Flowery Branch, 
GA). CdCl2, PMSF and protease inhibitor were purchased from Sigma-Aldrich 
(Dallas, TX). Bis-acrylamide powder, BCA kit and extracellular matrix components 
were purchased from Thermo-Fisher Scientiﬁc (Pittsburgh, PA). Phosphatase inhibitor 
cocktail tablets were purchased from Roche (Indianapolis, IN). Gelatin-zymogram gel, 
Laemmli buffer and blotting buffers were obtained from Bio-Rad (Hercules, CA). 
Phorbol 12-myristate 13-acetate (PMA) was purchased from Cayman Chemical (Ann 
Arbor, Michigan). Active-integrin β1, GAPDH antibodies, Amicon centrifugal filter 
units (NMWL 10), slide chambers and Transwell inserts were purchased from EMD 
Millipore (Billerica, MA). Phosphor Rac1, α-actinin, phosphor-ERK 1/2 (Thr 202/Tyr 
204), ERK, phosphor-Src (Tyr 416), Src, phosphor-FAK (Tyr 397) and FAK primary 
antibodies were from Cell Signaling Technology (Danvers, MA). CF5.5 goat anti-
rabbit IgG was purchased from Santa Cruz Biotechnology (Dallas, TX). IRDye 680 
goat anti-rabbit and goat anti-mouse IgG antibodies were purchased from Licor 
(Lincoln, NE). TOPFlash and pRL-TK plasmids were purchased from Addgene 
(Cambridge, MA). Nuclear Extract Kit was purchased from Active Motif (Carlsbad, 
CA). Cell Counting Kit-8 was purchased from Dojindo Molecular Technologies 
(Rockville, MD). Cultrex 3-D spheroid cell invasion assay kit was obtained from 
Trevigen (Gaithersburg, MD). E-PlateView 16-well plates were purchased from 
 70 
 
ACEA Biosciences (San Diego, CA). Dual-luciferase assay kit was from Promega 
(Madison, WI). 
 
Cell lines and cell culture 
Breast cancer derived MDA-MB-231 cells were obtained from American Type 
Culture Collection (Manassas, VA). The cells were cultured in DMEM supplemented 
with 10% FBS and penicillin (100 U/mL)/streptomycin (100 U/mL). Cells were 
maintained in a humidified incubator (37°C) with 5% CO2. 
 
Wound healing assay 
The wound healing assay was performed in a 12-well plate. MDA-MB-231 cells 
were seeded in three replicates and cultured in DMEM with 10 % FBS. Wounds were 
generated by scratching the 90% confluent cell monolayer with a 1-20 μl pipet tip. The 
unattached cells were washed away with PBS and attached cells were treated with 0.5-
1 μM Cd in 10 % FBS-supplemented DMEM. Images of the wounds were acquired 
every 24 h under phase contrast microscopy.  
 
Electrical impedance assay 
MDA-MB-231 cells were seeded at a density of 8,000 cells/well in E-PlateView 
16 plates and cultured in DMEM with 10% FBS. The bottom of the plate was covered 
with gold microelectrode sensors that generated an electric ﬁeld when a low voltage 
(less than 20 mV) was applied between electrodes.  Cells in the logarithmic growth 
phase were treated with DMEM containing 1 or 3 μM Cd and adhesion was monitored 
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by using xCELLigence RTCA system at a sweeping interval of 15 s. Results were 
profiled and plotted by using the RTCA software. 
 
Immuno-fluoresce staining  
MDA-MB-231 cells were seeded in slide chambers and grown in DMEM with 10 
% FBS. After 24 h, the cells were treated with 1 or 3 μM Cd in DMEM for 3 h. For 
specimen preparation, cells were fixed by treatment with 4% paraformaldehyde in 
PBS for 15 min followed by permeation with 0.3% Triton X-100 in 1% BSA-
supplemented PBS. Cells were then blocked in 5% BSA-supplemented PBS. Finally, 
the cells were incubated with primary antibody for α-actinin overnight. After washing 
with PBS for 5 min, three times, the cells were stained using secondary antibody, goat 
anti-rabbit IgG. Nuclei were stained with DAPI. Images of the stained cells were 
captured with a Nikon NE2000 fluorescence microscope. 
 
Western blot analysis 
Whole cell lysates were prepared in RIPA buffer. Nuclear and cytoplasmic 
fraction samples were prepared using an Active Motif nuclear extraction kit. Protein 
concentration in lysates was determined using the BCA kit. Proteins were denatured 
by heating the lysate to 95°C in Laemmli buffer containing 5% β-mercaptoethanol. 
Samples requiring non-reduced proteins were prepared in Laemmli buffer without β-
mercaptoethanol. Proteins in the samples were then separated by SDS-PAGE 
electrophoresis and transferred to nitrocellulose membranes. The membranes were 
incubated with 5% non-fat milk for 1 h followed by incubation with the primary 
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antibody overnight. The membranes were rinsed for 5 min three times in PBS 
containing 0.5% Tween 20, and incubated with secondary antibody for 1 h, followed 
by three additional washings in PBS containing 0.5% Tween 20, before imaging. The 
membranes were scanned by an Odyssey Infrared Imager. The optical density of the 
bands was quantiﬁed by the Odyssey image analysis software. 
 
Luciferase reporter assay 
MDA-MB-231 cells were seeded in 96-well plates and cultured in DMEM with 
10% FBS. After 24 h, the cells were transfected with pRL-TK (2 ng/well) and 
TOPFlash (50 ng/well) plasmids for 48 h. The cells were serum starved by incubating 
in blank medium overnight, prior to treatment with Cd for 8 h. Firefly and renilla 
luciferase activities were generated by using Promega Dual-Luciferase assay and 
measured in a Glomax luminometer. Relative luciferase activity was quantified as the 
ratio of firefly to renilla luciferase activities. 
 
Transwell assay 
Transwell compartments (8 μm pore size) were prepared and inserted in a 24-well 
plate. The membranes were coated with 2 μg/ml collagen, 2 μg/ml fibronectin, 8 
μg/ml vitronectin, and 8 μg/ml laminin. Cells were seeded into upper chambers in 
DMEM supplemented with 10% FBS. After a 48 h incubation, cells in the upper 
chamber were carefully removed with a cotton swab. The cells remaining on the 
underside of the membranes were ﬁxed in 70% ethanol for 10 min and then stained 
with 0.5% crystal violet solution. Membranes with stained cells were imaged using an 
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EVOS microscope at scan mode. To quantify the number of cells that migrated to the 
lower chamber, crystal violet stained cells were de-stained in 20% methanol. Migrated 
cell numbers in control and Cd-treated groups were determined by the absorbance of 
de-staining solutions at 450 nm in a Spectromax microplate reader. The relative 
migration tendency of Cd-treated cells was quantified as the ratio of absorbance 
reading by the treated cells over that of the control cells.  
 
Gel zymography analysis 
Precast gelatin-zymogram SDS-polyacrylamide gels were co-polymerized with 
gelatin. Media from cultured cells were concentrated 10 fold by centrifuging in 
Amicon filter unites at 4,000 g for 30 min before additing to non-denaturing loading 
buffer solution. Protein concentration of all samples was determined and normalized 
to the same level before loading the samples onto gels. Electrophoresis of gelatin-
zymogram gels was performed at 100V for 1 h. Gels were washed and incubated in 
renaturing buffer for 40 min and incubated in developing buffer overnight at 37°C. 
Then gels were stained with 0.1% coomassie R-250 brilliant blue for 1 h and washed 
for 30 min until clear bands developed. Gelatinolytic activity (relative intensity of 
clear bands) of secreted MMP 9 and MMP 2 was quantified by densitometry analysis 
using the Odyssey image analysis software.  
 
Cell proliferation assay 
Untreated and 4-week Cd-treated MDA-MB-231 cells were harvested and seeded 
in a 96-well plate at a density of 10,000 cells/well in DMEM supplemented with 10 % 
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FBS. After 4 days, cell growth was measured by Cell-Counting Kit 8. Absorbance was 
read at 450 nm and relative cell growth of Cd-treated cells was compared to untreated 
control cells.  
3D cell culture 
A spheroid invasion assay was used to estimate cell invasiveness. The experiment 
was performed by using a Cultrex 3-D spheroid cell invasion assay kit. Control and 4-
week Cd-treated cells were harvested and seeded at a density of 5,000 cells/well in 
low-adhesive round-bottom 96-well plates. The cells were cultured in DMEM 
supplemented with 10 % FBS and basal membrane extract. After 4 days, the cells 
assembled into a compact spheroid. At that point, matrigel was added to each well to 
provide a solidified invasion matrix. The growth of spheroids was observed 
microscopically and imaged daily.  
 
Data analysis 
All experiments were repeated at least three times. Western blot and zymography 
data were analyzed and quantified by Odyssey imaging analysis software. One-way 
ANOVA was performed by Prism with Tukey’s post hoc test on all data and p<0.05 
was considered statistically significant. 
 
Results 
Effects of Cd treatment on cytoskeletal dynamics 
In the wound healing assay, the scratches in 0.5 and 1 μM Cd treatment groups 
were healed by 48 h, while scratches in control group remained. These results 
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indicated that Cd induced MDA-MB-231 cell migration without producing visible 
cytotoxic effects (Fig. 1A).  
A real-time electrical impedance assay was used to track cell spreading. Adding 1 
or 3 μM Cd to attached cells caused an increase in the cell spreading index at both Cd 
concentrations and peaked around 4 h. (Fig. 1B). Cell migration and spreading was 
also assessed by using a dynamic cytoskeletal construction indicator, α-actinin, which 
cross-links actin filaments (Otey et al., 1990). Cells treated with Cd exhibited 
longitudinal filamentous α-actinin staining in 3 h (Fig. 1C). Its spatial distribution in 
filopodia indicated that Cd stimulated the buildup of cytoskeletal proteins for cell 
spreading and subsequently cell migration.  
 
Effects of Cd treatment on activation of integrin and downstream signaling 
Upon stimulation, integrin transduces adhesion signaling to focal adhesion 
kinases, which is essential in assembly of actin filaments (Mitra and Schlaepfer, 
2006). Effects of Cd treatment on integrin activation and downstream kinases were 
examined by Western blot. As shown in Fig. 2, treatment with 1 or 3 μM Cd or 100 
nM PMA (positive control) significantly increased active integrin β1 expression 2-fold 
in MDA-MB-231 cells. Cd-treated cells displayed a 1.4 - 2.3-fold increase in 
phosphorylation of FAK (Tyr 397) and Src (Tyr 416), which indicated activation of 
kinases at focal adhesion sites. Rac1 is a downstream target of focal adhesion kinase, 
and is involved with regulation of actin polymerization (Vial et al., 2003). Here, 1 or 3 
μM Cd elevated Rac1 phosphorylation 2.3-fold, which was associated with the 
appearance of filamentous α-actinin (Fig. 1C). Additionally, ERK 1/2 signaling was 
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activated by Cd treatment, presumably because of integrin pathway crosstalk with 
MAPK signaling (Vial et al., 2003). The activation of integrin itself and downstream 
signal transduction indicated that integrin was involved in Cd-induced cell adhesion. 
 
Effects of Cd treatment on β-catenin signaling and expression 
To examine activation of the Wnt/β-catenin pathway in Cd-treated breast cancer 
cells, the MDA-MB-231 cells were transfected with TOPflash plasmids which 
contained repeated TCF/LEF sites upstream of the luciferase reporter. As shown in 
Fig. 3A, treatment with 3 μM Cd increased luciferase activity in transfected cells 1.8-
fold, suggesting increased TCF/LEF transcription. This was further confirmed by the 
observation that Cd treatment enhanced phosphorylation of GSK3β (Ser 9) 1.5-fold, 
which led to GSK3β inhibition (Fig. 3B). Thus, the Wnt/β-catenin pathway was 
activated by Cd treatment. 
The distribution of β-catenin in cellular fractions was determined in MDA-MB-
231 cells treated with 3 μM Cd for 4 week. Western blot analysis showed that 
prolonged Cd treatment led to a 2.9-fold increase in β-catenin level in the whole 
lysate, a 1.9-fold increase in the cytosolic fraction, and a 1.9-fold increase in the 
nuclear fraction. Increasing β-catenin was accumulated in both the cytosol and the 
nucleus (Fig. 4A). Accumulation of β-catenin generated a larger pool of co-activator 
for TCF/LEF transcription. As shown in Fig. 4B, the luciferase activity in 4-week Cd-
treated cells was higher than 4-week untreated cells, indicating basal TCF/LEF 
transcription activity was elevated after the 4-week Cd treatment. Under the same 
treatment with 1 μM Cd, 4-week Cd-treated cells further increased TCF/LEF 
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transcription activity 2.8-fold over 4-week untreated cells. Therefore, the additional 
activation of TCF/LEF transcription in the 4-week Cd-treated cells seems to follow the 
increase in β-catenin expression.  
 
Effects of prolonged Cd treatment on cytoskeleton reorganization 
To study how prolonged Cd treatment affects the cytoskeleton, MDA-MB-231 
cells were treated with 3 μM Cd for 4 weeks. The Cd-treated cells stained with 
vimentin exhibited different spatial distribution of intermediate filaments when 
compared to control cells (Fig. 5A). The expression of not only vimentin but also 
integrins α5 and β1, and paxillin were increased by 5.3-, 2.1-, 6.3-, and 3-fold, 
respectively (Fig. 5B). The increases in intermediate filaments, integrins, and scaffold 
proteins indicated that prolonged Cd treatment re-organized the cytoskeleton.  
 
Effects of prolonged Cd treatment on metastatic potential  
Transwell assay and MMP secretion were used to assess cell migration and 
invasion. To evaluate the effect of Cd on cell proliferation, cell growth was compared 
between Cd-treated cells and control cells. Furthermore, the spheroid invasion assay 
was used to comprehensively examine invasion and proliferation. 
The microscopic pictures in Fig. 6A show that a greater number of Cd-treated 
cells than untreated cells migrated to the lower chamber and attached to the underside 
of the membrane in Transwell inserts. Quantified result indicated that 4 weeks of Cd 
treatment increased cell migration by 1.6-fold (Fig. 6A). Activities of MMP 2 and 9 in 
cell culture medium were detected by in-gel zymography. As shown in Fig. 6B, the 
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clear bands in the gel image indicated gelatinolytic activity of MMPs. Determined by 
molecular weight, the intensities of clear bands at 58 and 82 KDa represented 
activities of MMP 2 and 9, respectively. Together, the secretion of MMP 2 and 9 in 
Cd-treated cells was 3.4-fold higher than in the control cells.  
To investigate whether 4 weeks of treatment with 3 μM Cd altered growth rate of 
MDA-MB-231 cells, the cells were harvested and cultured in the absence of Cd for 4 
days.  As shown in Fig. 7, the pretreated cells exhibited 30% higher growth than the 
control cells.   
Invasiveness of prolonged Cd-treated cells was evaluated in a 3D spheroid 
invasion assay. The Cd-treated cells exhibited a shady outer ring around the spheroid 
core (arrow pointed), which indicated cell invasion into the surrounding matrigel (Fig. 
8). In control cells, this ring was evident on day 12. In comparison, the ring in 4-week 
Cd-treated cells began as early as on day 6. The Cd-treated cells thus migrated and 
invaded more aggressively than the control cells. 
 
Discussion 
Metastasis is a consecutive process which includes invasion into surrounding 
tissue, intravasation, extravasation, and colonization into secondary tumors (Nguyen et 
al., 2009). Cell movement during this process is conducted through sequential 
activation of cell adhesion receptors which dynamically regulate cytoskeletal 
construction, leading to cell spreading and migration (Felding-Habermann et al., 
2001).  
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The results presented here suggest that Cd enhances metastasized MDA-MB-231 
breast cancer cell attachment through integrin activation. Cells receiving prolonged Cd 
treatment aid malignancy, as evidenced by cytoskeleton reorganization and enhanced 
cell migration and invasion. Enhanced cell proliferation further facilitates metastasized 
cell growth. All of these changes are key indicators of metastasized cells migration to 
a new environment and growth into a secondary tumor. Moreover, cellular responses 
shortly after Cd treatment correlated with alterations in cells treated with Cd for 4 
weeks. First, short-term Cd treatment led to integrin β1 activation, which preceded cell 
adhesion and cell migration. Thus, prolonged Cd treatment elevated integrin α5 and β1 
expression and displayed markedly higher migration and invasion characteristics. 
Second, short-term Cd treatment activated β-catenin signaling. Prolonged Cd 
treatment elevated expression of β-catenin which rendered Cd-treated cells more 
responsive to the activation of Wnt/β-catenin signaling which contributed to cancer 
progression.    
Cd-induced cytoskeletal perturbation has been well studied in animal cells. 
Exposure to Cd leads to disassembly of microtubules in mouse 3T3 cells (Perrino and 
Chou, 1986). In Cd-treated mouse mesangial cells, actin filaments become irregular 
and are lost because of disturbances in focal adhesion (Choong et al., 2013). In 
contrast to these earlier findings of cytoskeleton disruption upon Cd treatment, the 
results of present study show that Cd increased α-actinin, a binder of actin filaments 
polymerization, indicating active cytoskeleton buildup in the MDA-MB-231 cells 
(Fig. 1C). Real-time tracking of cell attachment indicated that Cd treatment stimulated 
cell spreading. These results led to examination of the effects of Cd on receptors that 
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regulate cell adhesion (Huttenlocher et al., 1996). The present study is the first to 
report that low level Cd treatment induces cell adhesion through integrin activation 
(Fig. 2). In this study, it was found that Cd, instead of disrupting focal adhesion 
(Choong et al., 2013), induced phosphorylation of focal adhesion kinases in breast 
cancer cells. This is a significant finding, because metastatic colonization at distant 
sites requires activation of integrin-mediated signaling (Reticker-Flynn et al., 2012). 
Increased expressions of intermediate filament-vimentin and scaffold protein-paxillin 
upon Cd treatment for 4 weeks (Fig. 5) provided evidence of cytoskeleton 
reorganization (Fife et al., 2014). The elevation of vimentin increases focal contact 
size, which is critical for cancer cell movement (Tsuruta and Jones, 2003).  
Integrin plays an important role in tumor cell invasion and migration (Hood and 
Cheresh, 2002). Disseminated tumor cells use integrin and protease to develop a 
mesenchymal-type migration pattern (Friedl and Wolf, 2003). Several studies reported 
that integrin-associated MMPs became localized to cell-ECM sites when integrin was 
bound to the ECM (Mueller et al., 1999; Dumin et al., 2001). The present study 
observed an increase in total cell migration in cells treated with Cd for 4 weeks in the 
Transwell assay (Fig. 6A). Apparently, migrated cells had to degrade ECM on the 
membrane to enter the lower chamber because ECM blocked the membrane pores. 
The enhancement of MMP2/9 secretion (Fig. 6B) was parallel to integrin expression in 
Cd-treated breast cancer cells (Fig. 5B). Increases in integrin and MMP levels are 
important for local tumor invasion because their interactions likely facilitate ECM 
degradation. Moreover, enhanced MMP secretion also promotes the release of growth 
factors including transforming growth factor β (TGFβ) and vascular endothelial 
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growth factor (VEGF) (Bergers et al., 2000; Yu and Stamenkovic, 2000; Mu et al., 
2002). The released growth factors bind to membrane receptors which further 
stimulate cell proliferation and migration (Schenk et al., 2003). Therefore, the 
increased ERK1/2 phosphorylation in the present study (Fig. 2) might be a 
consequence of the release of growth factors. 
Canonical Wnt/β-catenin activation may facilitate carcinogenesis (Reya and 
Clevers, 2005) since it is marked by translocation of β-catenin to the nucleus with 
subsequent triggering of TCF/LEF transcriptional machinery. In this study, Cd 
activated TCF/LEF luciferase reporter in breast cancer cells (Fig. 3A), which was 
similar to observations reported previously in Cd-treated human kidney cells 
(Chakraborty et al., 2010a; Edwards et al., 2013). However, the related molecular 
events summarized in Fig. 9 were at variance with their previously reported 
mechanisms related to disruption of E-cadherin. For example, β-catenin, an important 
co-activator of TCF/LEF transcription, was caged by GSK3β for degradation. The 
result in Fig. 3B showed that Cd inhibited GSK3β, resulting in β-catenin’s escape 
from degradation. The free β-catenin translocated into the nucleus and increased 
TCF/LEF transcription (Fig. 3A). Furthermore, prolonged Cd treatment elevated the 
expression of β-catenin (Fig. 4A). Although the mechanism responsible for β-catenin 
accumulation remains unclear, some insight might be provided by the observation that 
upregulation of β-catenin rendered cells more responsive to Wnt/β-catenin pathway 
stimulation (Fig. 4B). 
Integrin signaling converges with the Wnt/β-catenin pathway at the GSK3β node 
(Burkhalter et al., 2011). The present study also examined whether Wnt/β-catenin 
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could be activated without engaging integrins. It was found that TCF/LEF 
transcription was diminished if cells were treated with Cd in low-adhesive plates (data 
not shown). This suggested that the involvement of integrin was important in Wnt/β-
catenin activation. Cd probably activated integrin-linked kinase (ILK), which in-turn 
inhibited GSK3β, resulting in β-catenin-initiated TCF/LEF transcription. In partial 
support of this hypothesis, it was found that prolonged Cd treatment increased both 
integrins and β-catenin expression. The observed increase in cell proliferation in these 
cells (Fig. 7) could be a combined effect of more active proliferative signaling by 
integrins and β-catenin.  
Breast tumor cells that migrate to distant organs frequently enter a long latency 
period before developing into life-threatening metastasized breast cancer. During this 
process, environmental factors may affect tumor malignancy. Therefore, it is 
important to understand how environmental risk contributes to breast cancer 
progression. Results reported here may provide some insight into this question. This 
study reports for the first time that a possible integrin-related mechanism is involved 
in the enhancement of breast cancer cell migration by the environmental contaminant 
Cd. Furthermore, it was shown that prolonged Cd treatment results in β-catenin 
accumulation, which renders breast cancer cells more sensitive to activate Wnt 
pathway. Extrapolating the in vitro observation of Cd-induced integrin activation, 
metastasized cancer cells might be more likely to lodge at distant organs after Cd 
exposure in vivo. There is growing evidence that tumor spheroids represent tumor 
conditions in vivo. Spheroids exhibit several traits which 2D monolayer cultures lack, 
such as characteristic tumor morphology, cell-cell contact, and hypoxic centers. The 
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results from this in vitro assay indicated that prolonged Cd treatment increases the 
tendency to form secondary tumors, which may shorten the latency of breast cancer 
relapse.  
In summary, it is concluded that Cd treatment activates integrin in breast cancer 
cells, substantially affecting cell adhesion and migration. Activation of TCF/LEF 
transcription upon Cd treatment can be explained as the result of Cd-induced GSK3β 
inhibition, which in turn could be the combined effects of integrin and β-catenin 
signaling. Activation of both pathways resulted in Cd-increased cell proliferation. 
Overall, it appears that Cd treatment increases the possibility of secondary tumor 
formation in metastatic sites. The results of this study contribute to a better 
understanding of Cd-induced breast cancer progression and may be of value in 
designing better strategies for cancer interventions in the future. 
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Figure 1. Cell spreading and adhesion in Cd-treated cells. 
(A) Wound healing assay. Before treatment with Cd, cross-scratches were made evenly 
on MDA-MB-231 cell monolayers. The cells were then treated with 0.5 or 1 μM Cd 
for 2 days. (B) Real-time electrical impedance assay. MDA-MB-231 cells in the 
logarithmic growth phase were treated with 1 or 3 μM Cd. Electrical impedance was 
measured every 15 s. Increased attachment between cell and electrode coated-plates 
was quantified as elevations in cell index. (C) Immuno-fluorescence staining for α-
actinin. Attached MDA-MB-231 cells were treated with 1 or 3 μM Cd for 3 h. Then 
cells were fixed and stained with α-actinin antibody. DAPI was added to the slide 
before microscopic imaging. Upper images were under 10 X objective lens. Lower 
images were taken under oil lens at 100 X. 
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Figure 2. Activation of integrin β1 and downstream signaling pathway upon Cd 
treatment.  
The cells were treated with 1 or 3 μM Cd for 15 min or 1 h. Cells treated with 100 nM 
PMA for 1 h were positive controls. Representative Western blot images of active 
integrin β1, pSrc (Tyr 416), pFAK (Tyr 397), pERK1/2 (Thr 202/Tyr 204), and pRac1 
are shown. Densities relative to the untreated control cells are plotted as mean±SEM 
(n =3). *Significantly higher than the untreated control group (p < 0.05). 
 
 95 
 
(A) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(B) 
 
 
 
 
 
 
 
 
 
                                15 min                          1 h           1 
        Control  Cd 1 μM  Cd 3 μM  Cd 1 μM  Cd 3 μM                             
pGSK3β (Ser 9) 
GSK3β 
GAPDH 
 
 96 
 
Figure 3. Effects of Cd treatment on the Wnt/β-catenin pathway.  
(A) Luciferase reporter assay. The cells were transfected with TOPflash and pRL-TK 
plasmids for 2 days. Transfected cells were serum-starved overnight and treated with 1 
or 3 μM Cd for 8 h. Firefly and renilla luciferase activities were then measured. The 
ratio of firefly to renilla luciferase activities was normalized to control. The relative 
luciferase activity is plotted as mean±SEM. (B) Inhibition of GSK3β. Serum-starved 
cells were treated with 1 and 3 μM Cd for 15 min or 1 h. Representative Western blot 
images of phosphorylated-GSK 3β (Ser 9) and GSK 3β are shown. Densities relative 
to the untreated control group are plotted as means±SEM (n =3). *Significantly 
different from the untreated control group (p < 0.05). 
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Figure 4. Effect of prolonged Cd treatment on β-catenin levels.   
The cells were cultured in DMEM supplemented with 3 μM Cd for 4 weeks. Control 
cells were cultured in medium alone. (A) Expression of β-catenin in cellular fractions. 
Representative western blot images of β-catenin expression are shown. Lamin A/C 
and GAPDH were loading controls for the nuclear and cytosol fractions, respectively. 
Densities relative to the respective fraction of 4-week untreated group are plotted as 
mean±SEM (n=3). (B) Luciferase reporter assay. Untreated and 4-week Cd-treated 
cells were transfected with TOPflash and pRL-TK plasmids and then serum-starved 
overnight, followed by treatment with 1 μM Cd for 8 h. Firefly and renilla luciferase 
activities were measured. The ratio of firefly and renilla luciferase activities was 
normalized to untreated control cells and plotted as mean±SEM. *Significantly higher 
than the 4-week untreated control group. #Significantly higher than 4-week untreated 
group that was treated with 1 μM Cd (p < 0.05). 
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Figure 5. Effects of prolonged Cd treatment on the cytoskeleton.  
The cells were cultured in DMEM containing 3 μM Cd for 4 weeks. Control cells 
were cultured in medium alone. (A) Immuno-fluorescence staining with vimentin. 
Cells were fixed and stained with vimentin antibody. DAPI was added to the slide 
before microscopic imaging. (B) Western blot of integrin α5 and β1, paxillin, and 
vimentin. Control and Cd-treated cells were seeded in 6-well plates. After 48 h, 
attached cells were harvested and analyzed for expression of integrin α5 and β1, 
paxillin, and vimentin and representative images are shown. Densities relative to the 
control cells are plotted as mean±SEM (n =3). *Significantly higher than the control 
cells (p < 0.05). 
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Figure 6. Effects of prolonged Cd treatment on cell migration.  
The cells were cultured in DMEM containing 3 μM Cd for 4 weeks. The control cells 
were cultured in medium alone. (A) Transwell assay. Control and Cd-treated cells 
were seeded in Transwell inserts. After 48 h, migrated cells were stained by crystal 
violet. Quantification of migrated cells was conducted by measuring the absorbance of 
de-staining solution. (B) Gelatin zymograph. Equal number of control and Cd-treated 
cells were cultured in serum-free medium for 2 days. The supernatant was 
concentrated 10-fold and applied to gelatin-zymogram gels. MMP2/9 secretion levels 
were visualized as the intensity of clear bands at 58 KDa and 82 KDa. Representative 
gel images are shown above the graph. Densities relative to those of the control cell 
group are plotted as mean±SEM (n=3). *Significantly different from control cells (p < 
0.05). 
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Figure 7. Effects of prolonged Cd treatment on cell proliferation.  
The cells were cultured in 10% FBS-supplemented DMEM containing either no Cd or 
3 μM Cd.  After 4 weeks, the cells were harvested and seeded at equal densities in 
DMEM supplemented with 10% FBS, but no Cd for 4 days. Cell proliferation was 
quantified using Cell Counting Kit-8. Absorbance at 450 nM relative to the control 
cells was plotted as mean±SEM (n=3). *Significantly higher than the control cells (p < 
0.05). 
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Figure 8. Effect of prolonged Cd treatment on cell invasion.  
The cells were cultured in DMEM supplemented with 3 μM Cd for 4 weeks. Control 
cells were cultured in medium alone. The cells were harvested and seeded in a round 
bottom 96-well plate at an equal density and grown in DMEM supplemented with 
basal membrane extract. Matrigel was added into each well after cells aggregated into 
spheroids. Cellular invasion of the spheroid was assessed by the appearance of a shady 
outer ring which was composed of cells invading into the matrigel. 
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Figure 9. Schematic diagram summarizing the effects of Cd on integrin and β-catenin 
signaling.  
(A) Cd activates integrins on the cell membrane. Focal adhesion kinase (FAK) then 
transduces integrin signaling to downstream Rac1 to regulate actin assembly. FAK-
initiated signaling also activates ERK 1/2 through crosstalk with MAPK, leading to 
cell proliferation. (B) At the same time, the active adhesion signaling is transduced to 
integrin-linked kinase (ILK) which inhibits GSK3β, resulting in β-catenin’s escaping 
from degradation. The free β-catenin translocates into the nucleus and stimulates 
TCF/LEF-mediated oncogene transcription, which contributes to carcinogenesis. 
